Home > Pressrelease > Joint Reconstruction Devices Market to exceed $25.3 Bn by 2027

Joint Reconstruction Devices Market to exceed $25.3 Bn by 2027

  • Published Date: May 19, 2021

Joint Reconstruction Devices Market size is set to surpass USD 25.3 billion by 2027, according to a new research report by Global Market Insights Inc.

Growing prevalence of orthopedic ailments is one of the prime factors increasing the penetration of joint reconstruction devices industry growth. Orthopedic diseases including osteoporosis, arthritis, rheumatoid arthritis, etc. have led to an increase in the number of joint reconstruction procedures across the globe. For instance, by 2040, it is estimated that around 78 million (26%) adults in the U.S. aged 18 years or older will have doctor-diagnosed arthritis.


Continuous surging infection rates leading to hip, shoulder, knee revision procedures has also led to an increase in joint reconstruction procedures. Joint reconstruction surgeries have proven to be the most reliable treatment option for degenerative joint diseases. There have been numerous technological advancements in joint reconstruction devices over the last 60 years to address the complications involved in arthroplasty which include restoration of function and implant loosening. Furthermore, the rising awareness pertaining to joint reconstruction surgeries and related procedures has significantly surged with an increasing prevalence of orthopedic diseases. Hence, the surge in diagnosis rate of musculoskeletal ailments, robot-assisted replacement surgeries, and reduced post-surgical complications are expected to boost the joint reconstruction devices market demand.

Rise in geriatric population in the Asia Pacific region will flourish the business growth

Increasing incidence of orthopedic disorders along with the growing geriatric population will promote the APAC joint reconstruction devices market revenue. The number of elderly people in the Asia Pacific region is growing at an unprecedented rate. The joint disorders are mostly related to aging and are expected to increase with an aging population. The elderly population leads to increased vulnerability pertaining to musculoskeletal injuries and disorders.

Significant osteoarthritis of the knee or hip might be further reported in 40% to 60% of elder adults. Osteoarthritis is the second most frequent rheumatologic ailment, and it is the most common joint disorder with a prevalence of around 22% to 39% in India. The prevalence of orthopedic ailments is surging owing to an aging population and a rise in related factors such as obesity, sedentary lifestyle, physical inactivity, etc. In 2017, about 146,189 arthroplasty procedures were performed in Japan with the peak age between the late 70s.

Browse key industry insights spread across 300 pages with 383 market data tables & 14 figures & charts from the report, “Joint Reconstruction Devices Market Size By Joint Type (Knee Replacement {Product [Primary Knee Systems, Revision Knee Systems, Partial Knee Systems], Component [Femoral Component, Tibial Component, Patellar Component]}, Hip Replacement {Product [Primary Hip Reconstruction Devices, Partial Hip Reconstruction Devices, Revision Hip Reconstruction Devices, Hip Resurfacing Devices], Component [Acetabular component, Femoral Component]}, Shoulder Replacement {Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Implants, Shoulder Arthroplasty Platform Implants}, Ankle Replacement {Two-Component Fixed Bearing, Three-Component Mobile Bearing}), COVID19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:

Increasing prevalence of orthopedic diseases in the Middle East and Africa

Growing prevalence of orthopedic ailments coupled with surging awareness about treatment options are some of the factors driving the regional joint reconstruction devices market demand. The changes in rheumatoid arthritis prevalence are anticipated across the Middle East and Africa due to socioeconomic, ethnic, and climate differences. Few countries in the region have developed rheumatoid arthritis specific treatment procedures to improve the understanding of the epidemiology and management of orthopedic ailments. Work related musculoskeletal disorders are highly prevalent in several African countries with the prevalence of any musculoskeletal ailments ranging from around 15% to 93.6%. About 20% of this total prevalence is contributed by the industrial area which includes mining.

At a regional level, the projected prevalence of rheumatoid arthritis ranged from 0.14% in Western Sub-Saharan Africa to 0.54% in urban areas across Africa. The significant growth of joint reconstruction surgeries are expected in the region due to the increasing awareness and adoption pertaining to joint reconstruction devices as it keeps joint mobility and provides significant pain relief.

Increased preference for ankle joint reconstruction devices in orthopedic settings will augment the market revenue

The joint reconstruction devices market size from ankle replacement segment is anticipated to expand at more than 5.9% CAGR to reach over USD 1.3 billion by 2027. Developments in designs, high efficiency, better affordability, and benefits over other conventional solutions is likely to fuel the segment demand. Moreover, major market players progressively emphasizing on improvements in joint reconstruction devices for the treatment of numerous ankle ailments and deformities. The demand for joint implants has been rising on account of surging life expectancy and the desire to stay active. Ankle replacement procedures are the most common replacement surgery in the U.S. after knee & hip replacement surgeries.

Factors such as new entrants in the market, increasing investments, and rising incidence of ankle fractures among elderly people along with the development of innovative products for ankle disorders treatment will drive the joint reconstruction devices market growth. The total ankle arthroplasty options are continuously in development with the introduction of novel implants and promising short to medium-term results.

However, the use of joint replacement devices is one of the recommended and successful options for the treatment of critical or permanent ankle joint injury owing to ankle joint infection. For instance, in around 90% of cases, ankle replacement lasts up to 10 years. Ankle replacement is very beneficial in lessening pain and preserving motion at the ankle. Hence, players in this market are focusing on providing innovative technologies for developing minimally invasive procedures and allowing faster recovery. Worldwide, osteoporosis causes over 8.9 million fractures every year.

Growing disease prone population in Japan is anticipated to fuel the market expansion

Japan joint reconstruction devices market surpassed around USD 934 million in 2020 impelled by rise in the number of joint reconstruction injuries, traumatic fractures, and increasing life expectancy among others. The rising disease prone population in Japan is offering business development opportunities to the industry players. As per the World Health Organization (WHO), the average life expectancy in Japan is 83.7 years.  Also, factors such as growing joint injuries and a medical tourism will drive the demand for joint replacement devices in Japan.

Surgical procedures required the use of joint reconstruction implants that are primarily coupled with implications that become more predominant in people with an upsurge in age comprising arthritis of the hip, knee, and shoulder.

Companies are focusing on strategies and launch of innovative products to expand customer base

Some of the major players operating in the joint reconstruction devices market are Stryker, Medtronic, Zimmer Biomet, DJO Global, ConforMIS, Smith & Nephew, NuVasive, MicroPort Scientific Corporation, Medacta, and Waldemar LINK among others. These players are emphasizing on product developments and strategic partnerships to progress in the market.

Authors: Sumant Ugalmugle, Rupali Swain